Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human 5HT3B Receptor ELISA Kit (AC2725)
Cat.#: ASET-1314
Specifications
Description Human 5HT3B Receptor ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human 5HT3B Receptor concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.59 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2509 Human Acetylcholinesterase ELISA Kit (AC3920) Quantitative inquiry ASET-1109 Human SNPH ELISA Kit (AC2520) Quantitative inquiry ASET-1843 Human CRCP ELISA Kit (AC3254) Quantitative inquiry ASET-1336 Human SOX6 ELISA Kit (AC2747) Quantitative inquiry ASET-2301 Human Granulin ELISA Kit (AC3712) Quantitative inquiry ASET-2303 Human DCC ELISA Kit (AC3714) Quantitative inquiry ASET-1637 Human PPAR gamma ELISA Kit (AC3048) Quantitative inquiry ASET-1524 Porcine ACTH ELISA Kit (AC2935) Quantitative inquiry ASET-1459 Human KALRN ELISA Kit (AC2870) Quantitative inquiry ASET-2100 Rat TrkB ELISA Kit (AC3511) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket